Yangling Metron New Material Inc.
SZSE:300861.SZ
38.45 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,271.103 | 4,511.935 | 3,658.245 | 1,847.652 | 1,205.321 | 1,193.293 | 2,157.858 | 1,242.137 | 184.575 | 0 |
| Cost of Revenue
| 1,865.654 | 2,245.306 | 1,719.411 | 828.421 | 523.84 | 531.439 | 786.378 | 358.753 | 54.92 | 0 |
| Gross Profit
| 405.448 | 2,266.628 | 1,938.834 | 1,019.231 | 681.481 | 661.854 | 1,371.48 | 883.384 | 129.655 | 0 |
| Gross Profit Ratio
| 0.179 | 0.502 | 0.53 | 0.552 | 0.565 | 0.555 | 0.636 | 0.711 | 0.702 | 0 |
| Reseach & Development Expenses
| 59.855 | 123.284 | 45.524 | 86.693 | 89.258 | 92.674 | 50.999 | 41.591 | 15.991 | 0.002 |
| General & Administrative Expenses
| 22.094 | 18.618 | 10.552 | 9.13 | 16.331 | -31.033 | -33.519 | -65.328 | -6.292 | 0.838 |
| Selling & Marketing Expenses
| 22.585 | 153.916 | 111.773 | 63.674 | 25.826 | 39.703 | 40.894 | 18.116 | 1.792 | 0 |
| SG&A
| 44.678 | 172.535 | 122.325 | 72.804 | 42.157 | 8.669 | 7.375 | -47.212 | -4.5 | 0.838 |
| Other Expenses
| 121.451 | 88.025 | -0.314 | -2.731 | -5.668 | -59.584 | -5.813 | 31.223 | 0.008 | -0 |
| Operating Expenses
| 225.984 | 379.928 | 213.56 | 171.246 | 153.445 | 108.37 | 163.754 | 84.269 | 17.476 | 0.84 |
| Operating Income
| 179.464 | 1,886.7 | 1,719.293 | 899.659 | 534.189 | 518.637 | 1,194.269 | 790.786 | 110.98 | -0.542 |
| Operating Income Ratio
| 0.079 | 0.418 | 0.47 | 0.487 | 0.443 | 0.435 | 0.553 | 0.637 | 0.601 | 0 |
| Total Other Income Expenses Net
| -4.475 | -10.702 | -0.314 | -2.731 | -5.668 | -47.896 | 3.784 | 5.047 | 0.007 | 0 |
| Income Before Tax
| 174.989 | 1,875.998 | 1,718.979 | 896.928 | 528.522 | 471.792 | 1,198.053 | 795.833 | 110.988 | -0.542 |
| Income Before Tax Ratio
| 0.077 | 0.416 | 0.47 | 0.485 | 0.438 | 0.395 | 0.555 | 0.641 | 0.601 | 0 |
| Income Tax Expense
| 31.925 | 281.602 | 244.302 | 133.752 | 75.909 | 63.2 | 173.65 | 118.297 | 16.984 | 0 |
| Net Income
| 145.523 | 1,588.614 | 1,472.913 | 763.176 | 449.669 | 407.678 | 1,024.403 | 677.536 | 94.004 | -0.542 |
| Net Income Ratio
| 0.064 | 0.352 | 0.403 | 0.413 | 0.373 | 0.342 | 0.475 | 0.545 | 0.509 | 0 |
| EPS
| 0.3 | 3.31 | 3.07 | 1.59 | 0.94 | 0.85 | 2.68 | 5.13 | 0.71 | 0 |
| EPS Diluted
| 0.3 | 3.31 | 3.07 | 1.59 | 0.94 | 0.85 | 2.68 | 5.13 | 0.71 | 0 |
| EBITDA
| 452.829 | 2,107.908 | 1,881.574 | 1,002.494 | 599.465 | 490.731 | 1,221.066 | 808.779 | 111.795 | -0.84 |
| EBITDA Ratio
| 0.199 | 0.467 | 0.514 | 0.543 | 0.497 | 0.411 | 0.566 | 0.651 | 0.606 | 0 |